Announcement on Holding Subsidiary Shuanghe Tian'an Pharmaceutical (Guizhou) Co., Ltd. Receiving the Drug Supplemental Application Approval for Pioglitazone Hydrochloride Dispersible Tablets
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment